Finnrick - Ensuring a Safer and More Transparent Supply Chain
Zhuoyue Biotechnology

Zhuoyue Biotechnology

Retatrutide

Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Zhuoyue Biotechnology between 21 Aug 2025 and 7 Mar 2026. Test scores average over 4, no score below 3, and at least 6 tests warrant a confident Finnrick Rating of D (Poor).

Finnrick Rating™
Zhuoyue Biotechnology
Retatrutide
Tested 7 Samples
Last test 7 Mar 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Zhuoyue Biotechnology

Samples are tested in commercial labs

Tests Count

7

Scores

AVG7.0MIN3.0MAX10.0

Last

7 Mar 2026

First

21 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
7 Mar 2026View7.815mg15.1mg+0.7%99.80%(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic
6 Mar 2026View10.010mg9.77mg-2.3%99.90%01/12/2026 Blue CapNo Label / Silver Crimp / Clear Blue CapLab EPublic
20 Feb 2026View5.015mg17.7mg+18.0%99.80%(no batch ID)White Label / Copper Crimp / Clear CapLab GPublic
11 Feb 2026View7.730mg31.8mg+6.0%99.90%(no batch ID)No Label / Silver Crimp / Black CapLab EPublic
19 Jan 2026View3.010mg8.84mg-11.6%88.42%(no batch ID)Black Label / Silver Crimp / Clear CapLab EPublic
19 Jan 2026View8.015mg14.6mg-2.7%99.95%(no batch ID)No Label / Silver Crimp / Pink CapLab EPublic
21 Aug 2025View7.620mg19.6mg-2.0%99.72%(no batch ID)No Label / Silver Crimp / Yellow Cap Lab EPublic